Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial

2019138 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: The Lancet. Gastroenterology & hepatology

Volume 5, Issue 1, pp. 31-41

Field-Weighted Citation Impact: 7.73